1.
J Infect
; 57(5): 414-5, 2008 Nov.
Artículo
en Inglés
| MEDLINE
| ID: mdl-18715650
RESUMEN
Temozolomide is a relatively new chemotherapeutic agent frequently associated with selective CD4+ T-lymphocytopenia. Patients with cell-mediated immune defects are at higher risk for acquiring infections with Salmonella species. We describe the first case of disseminated salmonellosis in a patient treated with temozolomide.